Kalap Holdings Limited investment portfolio

Gaman Succession is an entrepreneurial private‑equity project that acquires and operates small‑ to medium‑sized B2B technology companies in Western Europe, providing long‑term ownership, succession support and growth capital to preserve founders’ legacies.

Nexus BioQuest is a contract research organization that provides immunology‑focused services—including bespoke assay design, target validation and pre‑clinical studies—for drug discovery programs in immuno‑oncology, autoimmunity, inflammation and neuro‑inflammation. Its clients are pharmaceutical and biotechnology companies developing immune‑targeted therapeutics.